Table 2.
Hot Flash Scores (A) and Frequencies (B) During Treatment
A. Mean Hot Flash Scores | ||||||
---|---|---|---|---|---|---|
Placebo (N=91) | 1200 mg (N=88) | 800 mg (N=88) | ||||
Mean (SD) | N | Mean (SD) | N | Mean (SD) | N | |
Baseline | 17.28 (10.84) | 83 | 15.35 (10.53) | 81 | 16.02 (9.62) | 81 |
Week 1 | 15.52 (10.51) | 86 | 14.47 (11.10) | 78 | 14.28 (9.26) | 81 |
Week 2 | 13.29 (9.46) | 85 | 12.59 (10.01) | 78 | 12.68 (8.87) | 79 |
Week 3 | 12.34 (9.98) | 83 | 11.32 (10.72) | 76 | 12.29 (9.79) | 78 |
Week 4 | 12.02 (9.57) | 82 | 10.14 (8.61) | 73 | 11.73 (10.35) | 78 |
Week 5 | 11.63 (9.61) | 79 | 9.73 (9.19) | 67 | 11.77 (10.86) | 75 |
Week 6 | 11.17 (8.78) | 79 | 9.44 (8.99) | 67 | 11.61 (10.46) | 71 |
Week 7 | 10.71 (8.68) | 78 | 9.37 (9.24) | 67 | 11.92 (11.26) | 71 |
Week 8 | 11.42 (10.32) | 79 | 9.06 (8.87) | 66 | 12.17 (10.88) | 69 |
Repeated Measure (P-value) | Growth Curve Model (P-value) | |||||
Mg 1200 Vs. Placebo | 0.67 | 0.90 | ||||
Mg 800 Vs. Placebo | 0.13 | 0.26 |
B. Mean Hot Flash Frequencies | ||||||
---|---|---|---|---|---|---|
Placebo (N=91) | 1200 mg (N=88) | 800 mg (N=88) | ||||
Mean (SD) | N | Mean (SD) | N | Mean (SD) | N | |
Baseline | 8.89 (4.52) | 83 | 7.55 (3.89) | 81 | 8.48 (4.34) | 81 |
Week 1 | 8.04 (4.59) | 86 | 7.15 (4.13) | 78 | 7.83 (4.34) | 81 |
Week 2 | 7.26 (4.65) | 85 | 6.51 (4.19) | 78 | 7.12 (4.18) | 79 |
Week 3 | 6.97 (4.82) | 83 | 5.87 (4.21) | 76 | 6.73 (4.41) | 78 |
Week 4 | 6.73 (4.44) | 82 | 5.34 (3.76) | 73 | 6.39 (4.51) | 78 |
Week 5 | 6.45 (4.33) | 79 | 5.15 (4.00) | 67 | 6.31 (4.70) | 75 |
Week 6 | 6.37 (4.30) | 79 | 4.95 (4.04) | 67 | 6.34 (4.56) | 71 |
Week 7 | 6.18 (4.23) | 78 | 4.92 (4.13) | 67 | 6.43 (4.68) | 71 |
Week 8 | 6.38 (4.67) | 79 | 4.88 (4.02) | 66 | 6.61 (4.58) | 69 |
Repeated Measure (P-value) | Growth Curve Model (P-value) | |||||
Mg 1200 Vs. Placebo | 0.55 | 0.80 | ||||
Mg 800 Vs. Placebo | 0.25 | 0.39 |